When people swallow a pill, they expect the medicine to quickly reach the source of their pain or illness, but how well medications can be absorbed in the gastrointestinal tract is variable. Predicting that rate is a crucial step in a drug’s long journey from lab discovery to medicine chest.

Scientists at the Massachusetts Institute of Technology hope to accelerate that process with a new way to assess oral drug absorption, one they also say is more accurate than current approaches. A team led by two biomedical engineers, the prolific entrepreneur Robert Langer and the gastroenterologist Giovanni Traverso, has cultured a model GI tract from pig intestines that they assert better mimics the human digestive system than current models based on colorectal cancer cells. 

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy